PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsCort-108297
Cort 108297
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
251 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Knee osteoarthritisD020370EFO_0004616M171—1125
InflammationD007249MP_0001845——1—214
Adrenal insufficiencyD000309————1214
Trigger finger disorderD052582—M65.3———134
Shoulder painD020069—M25.51—1—113
Nervous system diseasesD009422—G00-G99—1—1—2
Congenital adrenal hyperplasiaD000312—E25.0—1—1—2
AnemiaD000740EFO_0004272D64.9——11—2
Addison diseaseD000224—E27.1———112
Cognitive dysfunctionD060825—G31.84—1—1—2
Show 20 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.0112515—145
Prostatic neoplasmsD011471—C614243——28
LymphomaD008223—C85.913184——28
Burkitt lymphomaD002051—C83.77136——23
B-cell lymphomaD016393——11141——21
Large b-cell lymphoma diffuseD016403—C83.311132——20
Precursor t-cell lymphoblastic leukemia-lymphomaD054218——585——14
LeukemiaD007938—C95285——13
Lymphoid leukemiaD007945—C91284——12
Castration-resistant prostatic neoplasmsD064129——171——8
Show 46 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AdenocarcinomaD000230——316———18
Non-hodgkin lymphomaD008228—C85.9710———13
CarcinomaD002277—C80.016———6
RecurrenceD012008——44———5
Neuroendocrine tumorsD018358EFO_1001901D3A.833———4
Cardiovascular diseasesD002318EFO_0000319I98—1——34
StrokeD020521EFO_0000712I63.9—1——34
Plasmablastic lymphomaD000069293—C83.332———3
Large-cell lymphoma immunoblasticD016400——32———3
Large-cell lymphoma anaplasticD017728—C84.623———3
Show 80 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.92————2
DepressionD003863—F33.91———12
Non-small-cell lung carcinomaD002289——1————1
Urogenital neoplasmsD014565EFO_0003863D071————1
ColitisD003092EFO_0003872K52.91————1
Deltaretrovirus infectionsD006800EFO_1001303—1————1
Htlv-i infectionsD015490EFO_0007316—1————1
Aids-related lymphomaD016483EFO_1001365—1————1
Composite lymphomaD058617——1————1
Fanconi anemiaD005199Orphanet_84D61.031————1
Show 5 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Heart failureD006333EFO_0003144I50————55
Giant cell arteritisD013700EFO_1001209M31.6————33
Polymyalgia rheumaticaD011111EFO_0008518M35.3————33
Hip osteoarthritisD015207EFO_1000786M16————33
Pituitary acth hypersecretionD047748EFO_1001110E24.0————22
ArthralgiaD018771—M25.5————22
TendinopathyD052256EFO_1001434M77.9————22
Rotator cuff injuriesD000070636—M75.1————22
Acute coronary syndromeD054058EFO_0005672—————22
ArteritisD001167EFO_0009011I77.6————22
Show 59 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCort 108297
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
127,937 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use